Rankings
▼
Calendar
INGN Q4 2024 Earnings — Inogen, Inc. Revenue & Financial Results | Market Cap Arena
INGN
Inogen, Inc.
$171M
Q4 2024 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$80M
+5.5% YoY
Gross Profit
$36M
45.3% margin
Operating Income
-$11M
-14.2% margin
Net Income
-$10M
-12.2% margin
EPS (Diluted)
$-0.41
QoQ Revenue Growth
-9.9%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$6M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$296M
Total Liabilities
$122M
Stockholders' Equity
$174M
Cash & Equivalents
$114M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$80M
$76M
+5.5%
Gross Profit
$36M
$28M
+28.9%
Operating Income
-$11M
-$29M
+60.7%
Net Income
-$10M
-$27M
+63.3%
Geographic Segments
UNITED STATES
$110M
65%
Non-US
$59M
35%
← FY 2024
All Quarters
Q1 2025 →